Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial

被引:154
|
作者
Rae, C [1 ]
Digney, AL
McEwan, SR
Bates, TC
机构
[1] Univ Sydney, Sch Mol & Microbial Biosci G08, Discipline Biochem, Sydney, NSW 2006, Australia
[2] Macquarie Univ, Macquarie Ctr Cognit Sci, N Ryde, NSW 2109, Australia
关键词
creatine; oral supplementation; intelligence; memory; brain bioenergetics;
D O I
10.1098/rspb.2003.2492
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Creatine supplementation is in widespread use to enhance sports-fitness performance, and has been trialled successfully in the treatment of neurological, neuromuscular and atherosclerotic disease. Creatine plays a pivotal role in brain energy homeostasis, being a temporal and spatial buffer for cytosolic and mitochondrial pools of the cellular energy currency, adenosine triphosphate and its regulator, adenosine diphosphate. In this work, we tested the hypothesis that oral creatine supplementation (5 g d(-1) for six weeks) would enhance intelligence test scores and working memory performance in 45 young adult, vegetarian subjects in a double-blind, placebo-controlled, cross-over design. Creatine supplementation had a significant positive effect (p < 0.0001) on both working memory (backward digit span) and intelligence (Raven's Advanced Progressive Matrices), both tasks that require speed of processing. These findings underline a dynamic and significant role of brain energy capacity in influencing brain performance.
引用
收藏
页码:2147 / 2150
页数:4
相关论文
共 50 条
  • [1] Safety and efficacy of creatine supplementation in juvenile dermatomyositis: a randomized double-blind placebo-controlled cross-over trial
    Adriana Sallum
    Marina Solis
    Ana Paula Hayashi
    Guilherme Artioli
    Marcelo Sapienza
    Maria Otaduy
    Ana Pinto
    Clóvis Silva
    Rosa Pereira
    Bruno Gualano
    Pediatric Rheumatology, 12 (Suppl 1)
  • [2] Creatine supplementation improves performance, but is it safe? Double-blind placebo-controlled study
    Almeida, Douglas
    Colombini, Alessandra
    Machado, Marco
    JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS, 2020, 60 (07): : 1034 - 1039
  • [3] A double-blind, placebo-controlled trial of creatine supplementation in patients with COPD
    Fuld, JP
    Kilduff, LP
    Neder, JA
    Lean, MEJ
    Pitsiladis, YP
    Ward, SA
    Cotton, MM
    THORAX, 2003, 58 : 79 - 79
  • [4] Creatine Supplementation in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Alves, Christiano R. R.
    Santiago, Bianca M.
    Lima, Fernanda R.
    Otaduy, Maria C. G.
    Calich, Ana Luisa
    Tritto, Aline C. C.
    de Sa Pinto, Ana Lucia
    Roschel, Hamilton
    Leite, Claudia C.
    Benatti, Fabiana B.
    Bonfa, Eloisa
    Gualano, Bruno
    ARTHRITIS CARE & RESEARCH, 2013, 65 (09) : 1449 - 1459
  • [5] ENOXIMONE IN CHRONIC STABLE ANGINA - A DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER TRIAL
    DUBREY, SW
    GNANASAKTHY, A
    STEIN, WK
    SONG, JG
    HARDMAN, T
    HYND, J
    NOBLE, MIM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (04) : 532 - 538
  • [6] A Mitochondrial Supplement Improves Function and Mitochondrial Activity in Autism: A Double-Blind Placebo-Controlled Cross-Over Trial
    Hill, Zoe
    Mccarty, Patrick J.
    Boles, Richard G.
    Frye, Richard E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [7] Double-blind, randomized, placebo-controlled, cross-over trial of pregabalin in essential tremor
    Ferrara, J. M.
    Kenney, C.
    Davidson, A. L.
    Shinawi, L.
    Kissel, A. M.
    Jankovic, J.
    MOVEMENT DISORDERS, 2009, 24 : S508 - S508
  • [8] Oral intake of carboxy alkyl ester improves attention: A randomized double-blind cross-over placebo-controlled study
    Guthrie, O'neil W.
    Yang, Li
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2023, 38 (06)
  • [9] High dose gabapentin for essential tremor: A double-blind, placebo-controlled, cross-over trial
    Jankovic, JJ
    Hunter, C
    Schwartz, K
    Ondo, WG
    NEUROLOGY, 1999, 52 (06) : A456 - A456
  • [10] LAMOTRIGINE THERAPY FOR PARTIAL SEIZURES - A MULTICENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSS-OVER TRIAL
    MESSENHEIMER, J
    RAMSAY, RE
    WILLMORE, LJ
    LEROY, RF
    ZIELINSKI, JJ
    MATTSON, R
    PELLOCK, JM
    VALAKAS, AM
    WOMBLE, G
    RISNER, M
    EPILEPSIA, 1994, 35 (01) : 113 - 121